Clinical Trial Update: Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled trial comparing budesonide/formoterol to Symbicort in asthmatic patients has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol (budesonide/formoterol)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Kindeva Drug Delivery | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2022-08-24